Changmao Biochemical: July 2026 Monthly Return Shows Stable Share Capital and Full Public Float Compliance

Bulletin Express
08/03

Changmao Biochemical Engineering Company Limited reported no changes in either authorised or issued share capital for the month ended 31 July 2026, according to its latest submission to Hong Kong Exchanges and Clearing Limited dated 03 August 2026.

The company’s authorised share capital remained at RMB 52.97 million, comprising: • 183.70 million H shares, par value RMB 0.1 each. • 2.50 million domestic shares, par value RMB 0.1 each. • 343.50 million foreign shares, par value RMB 0.1 each.

Issued share capital was also unchanged, standing at 529.70 million ordinary shares, split as follows: • 183.70 million H shares listed on the Stock Exchange. • 2.50 million unlisted domestic shares. • 343.50 million unlisted foreign shares.

No treasury shares were held or cancelled, and no new share options, warrants, convertible securities, or other equity-linked instruments were issued during the period.

Management confirmed that the company met the Exchange’s minimum 25% public-float requirement for its H-share class as at 31 July 2026.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10